Inventor · disambiguated record
Christopher J. Molineaux
Also filed as: MOLINEAUX CHRISTOPHER · MOLINEAUX CHRISTOPHER J
21 granted patents·9 pending applications·610 citations·filing 1994–2023
97Inventor score
Top patents by PatentIndex Score
30 records- 0195US10626090B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2017·Granted Apr 21, 2020·6 cites·10 claims
- 0295US6180608B1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 1997·Granted Jan 30, 2001·119 cites·50 claims
- 0394US5968895APharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 1996·Granted Oct 19, 1999·109 cites·32 claims
- 0493US10894774B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2017·Granted Jan 19, 2021·3 cites·23 claims
- 0593US10882827B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2018·Granted Jan 5, 2021·3 cites·24 claims
- 0692US9920011B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2013·Granted Mar 20, 2018·10 cites·6 claims
- 0791US8629131B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Jan 14, 2014·10 cites·11 claims
- 0891US8609646B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Dec 17, 2013·10 cites·9 claims
- 0991US8604012B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Dec 10, 2013·10 cites·11 claims
- 1091US5428128ASite specific synthesis of conjugated peptidesFiled 1994·Granted Jun 27, 1995·157 cites·29 claims
- 1189US11680048B2Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2020·Granted Jun 20, 2023·1 cites·14 claims
- 1289US6211153B1Methods for treating LHRH associated disorders with LHRH antagonistsPRAECIS PHARM INC·Filed 1999·Granted Apr 3, 2001·51 cites·33 claims
- 1388US8604013B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2010·Granted Dec 10, 2013·6 cites·13 claims
- 1487US2024182424A1Enhanced erythropoiesis and iron metabolismFIBROGEN INC·Filed 2023·Application pending·0 cites
- 1583US8614204B2Enhanced erythropoiesis and iron metabolismKLAUS STEPHEN J·Filed 2004·Granted Dec 24, 2013·8 cites·13 claims
- 1682US6384017B1Methods for treating sex hormone-dependent conditions with Lhrh antagonistsPRAECIS PHARM INC·Filed 2000·Granted May 7, 2002·10 cites·24 claims
- 1779US5780435AMethods for treating prostate cancer with LHRH-R antagonistsPRAECIS PHARM INC·Filed 1995·Granted Jul 14, 1998·27 cites·22 claims
- 1877US5843902AMethods for treating prostate cancer with LHRH antagonistsPRAECIS PHARM INC·Filed 1996·Granted Dec 1, 1998·25 cites·77 claims
- 1974US6180609B1Methods for treating LHRH associated disorders with LHRH antagonistsPRAECIS PHARM INC·Filed 1999·Granted Jan 30, 2001·20 cites·21 claims
- 2069US6699833B1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 1999·Granted Mar 2, 2004·17 cites·36 claims
- 2167US2017216274A1Enhanced Erythropoiesis and Iron MetabolismFIBROGEN INC·Filed 2017·Application pending·0 cites
- 2267US2017216248A1Enhanced Erythropoiesis and Iron MetabolismFIBROGEN INC·Filed 2017·Application pending·0 cites
- 2364US7109171B2Methods for treating FSH related conditions with GnRH antagonistsPRAECIS PHARM INC·Filed 2001·Granted Sep 19, 2006·3 cites·29 claims
- 2456US2009197813A1Methods for treating FSH related conditions with GnRH antagonistsGARNICK MARC B·Filed 2008·Application pending·0 cites
- 2552US2007185032A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2005·Application pending·0 cites
- 2652US2007185033A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2005·Application pending·0 cites
- 2751US6153586AMethods for treating prostate cancer with LHRH-R antagonistsPRAECIS PHARM INC·Filed 1998·Granted Nov 28, 2000·5 cites·28 claims
- 2850US2007015714A1Methods for treating FSH related conditions with GnRH antagonistsPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 2950US2003171296A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2000·Application pending·0 cites
- 3037US2016287564A1Methods of administering glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher J. Molineaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →